Association between serum albumin creatinine ratio and all-cause mortality in intensive care unit patients with heart failure

被引:2
作者
Wang, Jiuyi [1 ]
Li, Ni [2 ]
Mu, Yunkai [1 ]
Wang, Kai [3 ]
Feng, Guibo [1 ]
机构
[1] Chongqing Med Univ, Dept Gen Surg, Yongchuan Hosp, Chongqing, Peoples R China
[2] Chongqing Bishan Hosp Tradit Chinese Med, Dept Cardiol, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2024年 / 11卷
关键词
serum albumin creatinine ratio; intensive care unit; heart failure; mortality; risk stratification;
D O I
10.3389/fcvm.2024.1406294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The serum albumin creatinine ratio (sACR) has been established as a potential indicator for heart disease, however, its relationship with prognosis in intensive care unit (ICU) patients with heart failure remains uncertain. This study aimed to investigate the association between sACR levels and all-cause mortality ICU patients with heart failure. Methods: Clinical data from MIMIC-IV database was utilized for the analysis of ICU patients with heart failure. Patients were categorized into quartiles (Q1-Q4) based on sACR levels. Kaplan-Meier survival analysis and multivariate adjusted Cox regression models were employed to assess the association between sACR levels and mortality outcomes within 365 days. Subgroup analysis was used to evaluate the prognostic impact of sACR across diverse populations. Restricted cubic spline curves and threshold effect analysis were utilized to quantify the dose-response relationship between sACR levels and risk of all-cause mortality. Mediating effects analysis was conducted to present the involvement of albumin and creatinine in the association between sACR and outcomes. Results: The analysis encompassed a cohort of 4,506 patients, with Kaplan-Meier curves indicating that individuals with lower sACR levels exhibited an elevated risk of all-cause mortality (log-rank p < 0.001). Multivariate adjusted Cox regression and subgroup analysis demonstrated that individuals in Q2 [hazard ratio (HR) 0.82, 95%CI 0.71 similar to 0.96], Q3 (HR 0.76, 95%CI 0.64 similar to 0.91) and Q4 (HR 0.62, 95%CI 0.50 similar to 0.76) had a decreased risk of mortality compared to individuals in Q1 (lower levels of sACR) (p for trend < 0.001), and this inverse relationship was consistently observed across various subgroups. Subsequent restricted cubic spline analysis revealed a negative yet nonlinear relationship between sACR and all-cause mortality (p for nonlinear < 0.001), and threshold effect analysis indicated an effect threshold of 3.75. Additionally, mediating effects analysis emphasized that sACR influenced the outcome not only through serum albumin and creatinine pathways, but also through direct mechanisms. Conclusion: The study found that low levels of sACR were independently associated with an increased risk of one-year all-cause mortality in ICU patients with heart failure, with a threshold effect, which could potentially serve as an early warning indicator for high-risk populations.
引用
收藏
页数:8
相关论文
共 15 条
[1]   Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry [J].
Chioncel, Ovidiu ;
Ambrosy, Andrew P. ;
Filipescu, Daniela ;
Bubenek, Serban ;
Vinereanu, Dragos ;
Petris, Antoniu ;
Collins, Sean P. ;
Macarie, Cezar ;
Gheorghiade, Mihai .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (05) :331-340
[2]   Inflammation in acute heart failure [J].
Garofalo, Manuel ;
Corso, Rossana ;
Tomasoni, Daniela ;
Adamo, Marianna ;
Lombardi, Carlo M. ;
Inciardi, Riccardo M. ;
Gussago, Cristina ;
Di Mario, Carlo ;
Metra, Marco ;
Pagnesi, Matteo .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[3]   Association between serum albumin-to-creatinine ratio and clinical outcomes among patients with ST-elevation myocardial infarction after percutaneous coronary intervention: a secondary analysis based on Dryad databases [J].
Huang, Xiaoye ;
Liu, Yuchun ;
Zhong, Chuyang ;
Lin, Zengrui ;
Zheng, Binyun .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[4]   Trial of an Intervention to Improve Acute Heart Failure Outcomes [J].
Lee, D. S. ;
Straus, S. E. ;
Farkouh, M. E. ;
Austin, P. C. ;
Taljaard, M. ;
Chong, A. ;
Fahim, C. ;
Poon, S. ;
Cram, P. ;
Smith, S. ;
McKelvie, R. S. ;
Porepa, L. ;
Hartleib, M. ;
Mitoff, P. ;
Iwanochko, R. M. ;
MacDougall, A. ;
Shadowitz, S. ;
Abrams, H. ;
Elbarasi, E. ;
Fang, J. ;
Schull, M. J. ;
Mak, S. ;
Ross, H. J. ;
Udell, J. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01) :22-32
[5]   Association between serum albumin to serum creatinine ratio and mortality risk in patients with heart failure [J].
Li, Shiyang ;
Xie, Xiaoshuang ;
Zeng, Xiaobin ;
Wang, Shihai ;
Lan, Jianjun .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (11) :2345-2355
[6]   The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis [J].
Lv, Shubin ;
Ru, Songchao .
PLOS ONE, 2021, 16 (10)
[7]   EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) [J].
Maggioni, Aldo P. ;
Dahlstrom, Ulf ;
Filippatos, Gerasimos ;
Chioncel, Ovidiu ;
Crespo Leiro, Marisa ;
Drozdz, Jaroslaw ;
Fruhwald, Friedrich ;
Gullestad, Lars ;
Logeart, Damien ;
Fabbri, Gianna ;
Urso, Renato ;
Metra, Marco ;
Parissis, John ;
Persson, Hans ;
Ponikowski, Piotr ;
Rauchhaus, Mathias ;
Voors, Adriaan A. ;
Nielsen, Olav Wendelboe ;
Zannad, Faiez ;
Tavazzi, Luigi .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (07) :808-817
[8]   Low serum albumin: A neglected predictor in patients with cardiovascular disease [J].
Manolis, Antonis A. ;
Manolis, Theodora A. ;
Melita, Helen ;
Mikhailidis, Dimitri P. ;
Manolis, Antonis S. .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 102 :24-39
[9]   Pathophysiology and clinical evaluation of acute heart failure [J].
Mentz, Robert J. ;
O'Connor, Christopher M. .
NATURE REVIEWS CARDIOLOGY, 2016, 13 (01) :28-35
[10]  
Nseir W, 2021, ANN CLIN LAB SCI, V51, P557